Jun 11, 2025, 08:22
Mastering the Art of Platelet Transfusion: Dr. Akhil Breaks Down the Clinical Thresholds You Need to Know
In a recent insightful post on X, Dr. Akhil delivers a concise yet powerful breakdown of platelet transfusion thresholds—a critical guide for clinicians navigating invasive procedures in patients with thrombocytopenia.
“When will you want to transfuse platelets?
Typical Recommended Platelet Count Thresholds for Common Procedures
Platelet transfusion may be considered when the patient’s platelet count is below the threshold for the corresponding procedure.
Neurosurgery or ocular surgery – <100,000/microL
Most other major surgery – <50,000/microL
Endoscopic procedures – <50,000/microL for therapeutic procedures; 20,000/microL for low risk diagnostic procedures
Bronchoscopy with bronchoalveolar lavage (BAL) – <20,000 to 30,000/microL
Central line placement – <20,000/microL
Lumbar puncture – <10,000 to 20,000/microL in patients with hematologic malignancies and <40,000 to 50,000 in patients without hematologic malignancies; lower thresholds may be used in patients with immune thrombocytopenia (ITP)
Neuraxial analgesia/anesthesia – <80,000/microL
Bone marrow aspiration/biopsy – <20,000/microL
Actively bleeding patients with thrombocytopenia should be transfused with platelets immediately to keep platelet counts >50,000/microL in most bleeding situations including disseminated intravascular coagulation (DIC), and >100,000/microL if there is central nervous system bleeding
Source : UpToDate”
Remember: Actively bleeding patients require immediate transfusion. Timely action can be lifesaving, especially in cases of CNS bleeding or DIC.”
See the full breakdown and expert commentary now on Hemostasis Today.
-
Sep 12, 2025, 06:39Chokri Ben Lamine: Approach to Intra-Operative Bleeding in G6P Deficiency – Key Causes and Management
-
Sep 11, 2025, 15:42The True Price of Gene Therapy: Breaking Down Beqvez’s $3.5M Cost and What Really Drives It
-
Sep 11, 2025, 14:49Samantha Nelson Shares "The Beat" - World Thrombosis Day Just Added Newsletter to LinkedIn
-
Sep 11, 2025, 13:01Do Not Miss ISTH Fast Five! Pediatric and Neonatal Thrombosis & Hemostasis and Many More Webinars
-
Sep 11, 2025, 08:33Alfonso J. Tafur Shares VascuLearn’s Free Virtual Support Groups This Fall for Patients and Providers
-
Sep 12, 2025, 06:21Flora Peyvandi on Why Plasminogen Activation Is Not Required to Prevent Venous Thrombosis
-
Sep 12, 2025, 03:38Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
-
Sep 11, 2025, 15:03Rapid ADAMTS13 Assays: A Key Milestone in the 100 Years of Innvoation in TTP Diagnosis - Silvio Castagni
-
Sep 11, 2025, 14:25Thrombin Generation Assays to Assess COC-Associated Procoagulant Alterations
-
Sep 11, 2025, 13:55Transplantation-Mediated Alloimmune Thrombocytopenia: Mostafa Faisal Mohammed Saleh Presents a Rare Case
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 11, 2025, 15:27Postpartum Haemorrhage: In Kenya, More than 120 Mothers Die for Every 100,000 Live Births
-
Sep 11, 2025, 15:11Join the Global Effort: World Thrombosis Day Campaign for Healthcare and Community Organizations
-
Sep 11, 2025, 14:26José Antonio García Erce: Self-Sufficiency in Blood Products - Utopia or Reality?
-
Sep 11, 2025, 08:08Al-Ola A Abdallah on MGUS-Related Bleeding Disorders
-
Sep 10, 2025, 19:32Denis Brutus Oduor: Call for Altruism in Blood Donation in Nairobi
Sep 12, 2025, 05:27